Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Likang Li

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Mediators of Inflammation|February 21, 2025
Selenium Nanoparticles Decorated With Stevioside Potentially Attenuate Fructose Palmitate Induced Lipid Accumulation in HepG2 CellsShuai Li, Hui Yang, Wenjun Zhou, et al.
Diabetes & Metabolic Syndrome|July 21, 2024
Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological surveyJingyi Zhang, Miaoguan Peng, Jianfeng Li, et al.
Diabetes & Metabolic Syndrome|June 14, 2023
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitusJingyi Zhang, Harriette Gc Van Spall, Likang Li, et al.
Journal of Clinical Epidemiology|June 5, 2024
Journal requirement for data sharing statements in clinical trials: a cross-sectional studyJingyi Zhang, Yingxin Liu, Lehana Thabane, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Mediators of Inflammation|February 21, 2025
Selenium Nanoparticles Decorated With Stevioside Potentially Attenuate Fructose Palmitate Induced Lipid Accumulation in HepG2 CellsShuai Li, Hui Yang, Wenjun Zhou, et al.
Diabetes & Metabolic Syndrome|July 21, 2024
Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological surveyJingyi Zhang, Miaoguan Peng, Jianfeng Li, et al.
Diabetes & Metabolic Syndrome|June 14, 2023
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitusJingyi Zhang, Harriette Gc Van Spall, Likang Li, et al.
Journal of Clinical Epidemiology|June 5, 2024
Journal requirement for data sharing statements in clinical trials: a cross-sectional studyJingyi Zhang, Yingxin Liu, Lehana Thabane, et al.
Pageof 3